Massive U.S. drug spending gives Trump trade leverage [Globe and Mail, The (Toronto, Canada)]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Globe and Mail, The
Fred Prouser/Reuters And when you put U.S. drug spending in a global context, it is easy to see why. Or, to put it another way, Americans spend more on medication than every other country in the world combined. The gap has widened over time, according to data from the Patented Medicine Prices Review Board, a Canadian federal body. The latest report , published Wednesday, showed the U.S. was the source of 50.6 per cent of global medicine sales in 2024. A decade ago, it was 40.4 per cent. Most developed countries have prices in the same ball park, with Canada tending towards the high end. (Canada was fifth-highest in 2024.) But the U.S. is in a league of its own: last year the average U.S. drug price was 264 per cent higher than in Canada. One big reason why the U.S. pays more is that it has not, historically, used its public health plans to try to negotiate better prices. That began to change under former president Joe Biden, and Mr. Trump is moving even more aggressively.
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- China's Licensing Trends Shaping Global Drug Development Analysis Report 2025: Parent Companies Benefitted from Upfront Payments for R&D, Gaining Equity in Novel Chinese Therapeutics [Yahoo! Finance]Yahoo! Finance
- Has AstraZeneca's Strong 30% Rally Left Further Upside in 2025? [Yahoo! Finance]Yahoo! Finance
- AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASHBusiness Wire
- Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
AZN
Sec Filings
- 12/4/25 - Form 6-K
- 12/1/25 - Form 6-K
- 12/1/25 - Form 6-K
- AZN's page on the SEC website